Home › Funds › Opaleye Management Inc. › ANNX
Opaleye Management Inc. position in ANNX
ANNEXON INC · Health Care
Opaleye Management Inc. reported holding 1,714,451 shares of ANNX (ANNEXON INC) in its Q2 2026 13F filing — a position valued at US$9.8M, representing 0.89% of its reported portfolio and ranking #28 among its reported holdings. Opaleye Management Inc. has disclosed ANNX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s ANNX position evolved
Opaleye Management Inc. first disclosed a stake in ANNX in Q3 2025 at 2,600,000 shares (US$7.9M). The position peaked in Q4 2025 at 2,600,000 shares, worth US$13.1M. Across 4 filings, Opaleye Management Inc. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,714,451 shares valued at US$9.8M — a reduction of -617,310 shares quarter over quarter.. Notable position changes include a 26% trim in Q2 2026 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 2.60M | $7.93M | New |
| Q4 2025 | 2.60M | $13.05M | Hold |
| Q1 2026 | 2.33M | $12.92M | Reduce |
| Q2 2026 | 1.71M | $9.79M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANNX and 13F data
ANNX (ANNEXON INC) is a Health Care company. 45 other funds we track also report a position in ANNX — the largest reported positions include Redmile Group, LLC (US$67.8M), BVF INC/IL (US$49.7M), MAK CAPITAL ONE LLC (US$33.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANNX
- Redmile Group, LLC 11.87M sh · $67.78M · Q2 2026
- BVF INC/IL 8.70M sh · $49.67M · Q2 2026
- MAK CAPITAL ONE LLC 5.86M sh · $33.47M · Q2 2026
- Siren, L.L.C. 4.46M sh · $25.46M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 4.44M sh · $25.34M · Q2 2026
- Bellevue Group AG 4.10M sh · $23.41M · Q2 2026
- MPM BioImpact LLC 3.54M sh · $20.24M · Q2 2026
- GREAT POINT PARTNERS LLC 3.50M sh · $19.98M · Q2 2026
- Palo Alto Investors LP 2.95M sh · $16.83M · Q2 2026
- Logos Global Management LP 1.50M sh · $8.56M · Q2 2026
- Tetragon Partners GP Ltd 1.24M sh · $7.09M · Q2 2026
- Ishara Investments LP 820.00K sh · $4.68M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held ANNX?
Opaleye Management Inc. has disclosed ANNX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Opaleye Management Inc.'s current position in ANNX?
As of Q2 2026, Opaleye Management Inc. holds 1.71M shares of ANNX (ANNEXON INC), valued at $9.79M, representing 0.89% of its reported portfolio and ranking #28.
Has Opaleye Management Inc. been buying or selling ANNX?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. reduced its position in ANNX. The position peaked in Q4 2025 at 2.60M shares.
Which other funds hold ANNX?
Other major institutional holders of ANNX include Redmile Group, LLC, BVF INC/IL, MAK CAPITAL ONE LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.